Veraxa Biotech AG

Last updated September 27, 2026

Organization details

Legal name
Veraxa Biotech AG
Former names
Veraxa Biotech Holding AG
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Switzerland
Headquarters city
Zurich
Headquarters country
Switzerland
Fiscal year end
December
Ticker symbol
VRXA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0002079109

Board of directors

Chief executives

Christoph Rudiger Antz · Chief Executive Officer
Since June 2026

Board connections

1 of this board's directors also sit on 3 other boards. 1 is in the same sector.

Network of Veraxa Biotech AG's board connections Cardio Diagnostics Holdings Inc. Cardio Diagnostics Hol... General Purpose Acquisition Corp. General Purpose Acquis... Nutex Health Inc. Nutex Health Inc. Warren Hosseinion Warren Hosseinion Veraxa Biotech AG
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$125,333
5 purchases by 4 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 28, 2026 Marc Gruninger Director Open-market purchase +9,133 $1.00 $9,133
Oct 27, 2026 Marc Gruninger Director Open-market purchase +867 $0.98 $850
Oct 20, 2026 Christoph Samuel Ziegler Director Open-market purchase +30,000 $1.09 $32,700
Aug 27, 2026 Christoph Rudiger Antz Director, Officer (Chief Executive Officer) Open-market purchase +5,000 $1.53 $7,650
Aug 27, 2026 Oliver Rolf Baumann Director Open-market purchase +50,000 $1.50 $75,000

Organizations in the same sector, closest in location and size first.

Questions about Veraxa Biotech AG

Who is the CEO of Veraxa Biotech AG?

Christoph Rudiger Antz has been Veraxa Biotech AG's Chief Executive Officer since June 2026.

How many directors are on Veraxa Biotech AG's board?

Veraxa Biotech AG's board has 5 directors: Christoph Rudiger Antz, Christoph Samuel Ziegler, Marc Gruninger, Oliver Rolf Baumann and Warren Hosseinion.

Are Veraxa Biotech AG insiders buying or selling shares?

Over the last 12 months, Veraxa Biotech AG insiders bought $125,333 of shares in 5 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="veraxa-biotech-ag"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.